During the past decade, Hospital Serdang conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Serdang" #1 sponsor was "Universiti Putra Malaysia" with 4 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Actelion" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Serdang" #1 collaborator was "Ministry of Health, Malaysia" with 2 trials as a collaborator, "Hamilton Health Sciences Corporation" with 1 trials as a collaborator, "Malaysia Palm Oil Board" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Medtronic Japan Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Serdang" are "Atrial Fibrillation" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Hospital Serdang" in a lesser frequency.

Most popular intervention types in "Hospital Serdang" are "Drug" (13 trials), "Dietary Supplement" (3 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "AT-1501" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Serdang" are 29 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Serdang". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Serdang, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Serdang, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".